Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

Q1 2014

XLV Guru Trades in Q1 2014

John Burbank 17,173 sh (New)
Jim Simons 55,700 sh (+1060.42%)
Ken Fisher 168,513 sh (+6.27%)
Stanley Druckenmiller 193,300 sh (+2.66%)
Steven Cohen 767,500 sh (unchged)
Louis Moore Bacon 50,000 sh (-90.85%)
» More
Q2 2014

XLV Guru Trades in Q2 2014

Louis Moore Bacon 651,090 sh (+1202.18%)
Ken Fisher 226,412 sh (+34.36%)
Steven Cohen 182,500 sh (unchged)
Stanley Druckenmiller 172,300 sh (-10.86%)
Jim Simons 11,400 sh (-79.53%)
» More
Q3 2014

XLV Guru Trades in Q3 2014

Ken Fisher 234,798 sh (+3.70%)
Stanley Druckenmiller 172,300 sh (unchged)
Louis Moore Bacon 519,090 sh (-20.27%)
» More
Q4 2014

XLV Guru Trades in Q4 2014

Jim Simons 19,300 sh (New)
Ken Fisher 247,355 sh (+5.35%)
Steven Cohen 50,000 sh (unchged)
Louis Moore Bacon 45,000 sh (unchged)
Louis Moore Bacon 256,000 sh (-50.68%)
» More
» Details

Insider Trades

Latest Guru Trades with XLV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
EV-to-EBIT 7.50
XLV's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 7.50 )
XLV' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 7.5

PEG 1.20
XLV's PEG is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 1.20 )
XLV' s 10-Year PEG Range
Min: 0   Max: 1.2
Current: 1.2

0
1.2

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.00
XLV's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 2.00 )
XLV' s 10-Year Dividend Yield Range
Min: 0   Max: 0
Current: 2

Yield on cost (5-Year) 2.00
XLV's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 2.00 )
XLV' s 10-Year Yield on cost (5-Year) Range
Min: 0   Max: 0
Current: 2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.00
XLV's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 2.00 )
XLV' s 10-Year Price/Tangible Book Range
Min: 0   Max: 0
Current: 2

Business Description

Industry: »
Compare:KH, CTFO, GBG, URGP, GPRM » details
» More Articles for XLV

Headlines

Articles On GuruFocus.com
S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 


More From Other Websites
Pfizer’s Global Vaccines, Oncology & Consumer Healthcare Segment Mar 31 2015
Biotech -Monthly reversal pattern in play at resistance Mar 31 2015
M&A drivers for 2015 Mar 31 2015
The Bull Case: Supply & Demand Edition Mar 31 2015
Technical Market Outlook: Breadth, Momentum, Options, & Sectors Mar 31 2015
What to watch at the end of the quarter Mar 30 2015
Healthcare ETFs Moving On UnitedHealth Deal Mar 30 2015
Biopharmaceutical Business: Why It’s Important for Pfizer Mar 30 2015
Must-Know: Aetna’s Key Mergers and Acquisitions Mar 30 2015
These positions hurt hedge funds the most last week Mar 30 2015
8:26 am Recap of Merger Monday in the healthcare space Mar 30 2015
What Drives Generic Pharmaceuticals’ Valuation? Mar 28 2015
Generic Companies Are Fighting for Market Share Mar 28 2015
Specialty Generics: Why Are They Getting More Attention? Mar 28 2015
Affordable Pricing Is Driving the Generic Drug Market Mar 28 2015
How Aetna Generates Value for its Shareholders Mar 28 2015
Farallon Capital Increases Position in Covidien Mar 28 2015
The Pharmacyclics–AbbVie Merger: What Are the Details? Mar 28 2015
How Does Aetna Compare with Its Peers in Valuation? Mar 28 2015
How the NAIC’s Capital Requirements Affect Aetna Mar 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK